From the February 15, 2018 version of this document, “MDL Statistics Report – Distribution of Pending MDL Dockets by Actions Pending” (accessed 2/21/18), published by the United States Judicial Panel on Multidistrict Litigation (JPML), we get the current number of cases filed in each of the four federal court Multidistrict Litigation (MDL) cases … [Read more...]
Pancreatic Cancer Lawsuits Reinstated for Incretin-Based Diabetes Drugs
Background Among the several different types of therapies indicated for treating type 2 diabetes are increatin mimetics. The medications approved by the FDA that fall into this class of drugs are: Byetta (exenatide) Bydureon (exenatide) Januvia (sitagliptin) Janumet (sitagliptin) Victoza (liraglutide) Previous scientific … [Read more...]